Nationwide Fund Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,964	Closed	-$936K	–	88
2017 Q3	$936K	Sell	7,964 -3,233	-29%	-$276K	﹤0.01%	1836
2017 Q2	$893K	Sell	11,197 -386	-3%	-$24.7K	﹤0.01%	1847
2017 Q1	$594K	Buy	11,583 +2,707	+30%	+$125K	﹤0.01%	2063
2016 Q4	$332K	Sell	8,876 -36,663	-81%	-$1.54M	﹤0.01%	2384
2016 Q3	$3.09M	Sell	45,539 -500	-1%	-$35.3K	0.01%	1194
2016 Q2	$2.56M	Sell	46,039 -7,436	-14%	-$468K	0.01%	1250
2016 Q1	$3.36M	Sell	53,475 -3,033	-5%	-$202K	0.01%	1121
2015 Q4	$5.32M	Buy	56,508 +8,742	+18%	+$811K	0.02%	885
2015 Q3	$3.84M	Sell	47,766 -3,088	-6%	-$343K	0.02%	1053
2015 Q2	$6.1M	Sell	50,854 -14,370	-22%	-$1.72M	0.03%	864
2015 Q1	$6.81M	Sell	65,224 -6,031	-8%	-$611K	0.03%	820
2014 Q4	$6.91M	Sell	71,255 -12,610	-15%	-$1.17M	0.03%	763
2014 Q3	$6.55M	Sell	83,865 -1,860	-2%	-$120K	0.03%	795
2014 Q2	$5.42M	Sell	85,725 -44,275	-34%	-$2.63M	0.02%	935
2014 Q1	$8.73M	Sell	130,000 -3,450	-3%	-$267K	0.04%	570
2013 Q4	$8.59M	Buy	133,450 +3,913	+3%	+$233K	0.04%	651
2013 Q3	$8.29M	Sell	129,537 -3,663	-3%	-$183K	0.04%	623
2013 Q2	$4.13M	Buy	+133,200	New	+$3.54M	0.02%	903